State Ledger
Company profile

FATE THERAPEUTICS INC CIK 1434316

Ticker
FATE (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
San Diego, CA 92131
Fiscal year end
2025 (FY)
Market Data
Close
$2.17
Change
+$0.04
Change %
1.88%
Volume
59,889

FATE · trading date Oct 9, 2026 · previous close $2.13 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$6.65M
Net income
-$136.32M
Total assets
$318.94M
Total liabilities
—
Stockholders' equity
$207.18M
Cash & equivalents
$46.63M
Operating income
-$147.70M
Operating cash flow
-$106.08M
Capital expenditures
$5.95M

Fiscal year 2025, via 10-K filed 2026-02-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-2,222.4%
Net margin
-2,051.1%
Free cash flow
-$112.04M
Free cash flow margin
-1,685.8%
Liabilities / assets
—
Equity / assets
65.0%
CapEx / revenue
89.6%
Operating cash flow / net income
0.78×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $6.65M -$136.32M $318.94M — $207.18M
2024 $13.63M -$186.26M $440.69M — $318.73M
2023 $63.53M -$160.93M $506.22M — $368.42M
2022 $96.30M -$281.72M $705.56M — $483.94M
2021 $55.85M -$212.15M $921.46M — $678.84M
Company Details
SIC code
2836
Active filer
Yes
Most recent SEC filing
Form S-8
2026-08-13
Financials filed via
Form 10-K
filed 2026-02-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
San Diego, CA 92131
12278 SCRIPPS SUMMIT DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:16 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies